Key facts
- This page summarizes Scott Laverne Howell's Form 3 filing for Vanda Pharmaceuticals Inc. (VNDA).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 13 Apr 2026, 17:37.
Scott Laverne Howell - 01 Apr 2026 Form 3 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)
- Reporting relationship
- VP and Chief People Officer
- Issuer ticker
- VNDA
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Scott Laverne Howell
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Scott Laverne Howell filed Form 3 for Vanda Pharmaceuticals Inc. (VNDA) on 13 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002128384
Primary reporting owner
Howell Scott Laverne
- Relationship
- VP and Chief People Officer
- Address
- 2200 PENNSYLVANIA AVENUE NW, SUITE 300E, WASHINGTON
- Signature
- /s/ Scott Laverne Howell
- Signature date
- 13 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VNDA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 99,360
- Date
- 01 Apr 2026
- Ownership
- Direct
VNDA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,175
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
VNDA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 50,000
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F2
VNDA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,000
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F3
VNDA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100,000
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F4
VNDA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,620
- Date
- 01 Apr 2026
- Ownership
- By Foundation
- Footnotes
- F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VNDA
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 77,500
- Exercise price
- $7.05
- Footnotes
- F6
VNDA
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 61,200
- Exercise price
- $11.36
- Footnotes
- F7
VNDA
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,600
- Exercise price
- $20.28
- Footnotes
- F7
VNDA
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $11.32
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest in full on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through such vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
Footnote F2
Represents shares of common stock underlying an RSU award. One-half of the RSU will vest on March 1, 2027, and the remaining one-half of the RSU will vest on March 1, 2028, provided the Reporting Person remains continuously employed by the Issuer through each vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.
Footnote F3
Represents shares of common stock underlying an RSU award. The RSU vests as follows: 1/3 will vest on March 1, 2027, 1/3 will vest on March 1, 2028, and the remaining 1/3 will vest on March 1, 2029, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.
Footnote F4
Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.
Footnote F5
Represents securities held by a foundation controlled by the Reporting Person and his family members.
Footnote F6
The option vests in equal monthly installments on the 16th day of each month through February 16, 2027, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
Footnote F7
The option is fully vested and immediately exercisable.